Healthcare provider profile · identity verified

Michelle Cornacchia

Internal Medicine · DANVILLE, PA · NPI 1144665977

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	190	53
Lisinopril	Lisinopril	181	42
Levothyroxine Sodium	Levothyroxine Sodium	170	40
Omeprazole	Omeprazole	129	34
Famotidine	Famotidine	115	25
Losartan Potassium	Losartan Potassium	108	29
Hydrochlorothiazide	Hydrochlorothiazide	92	27
Sertraline Hcl	Sertraline Hcl	83	14
Furosemide	Furosemide	73	18
Trazodone Hcl	Trazodone Hcl	73	19
Amlodipine Besylate	Amlodipine Besylate	71	19
Carvedilol	Carvedilol	67	15
Montelukast Sodium	Montelukast Sodium	64	14
Duloxetine Hcl	Duloxetine Hcl	63	15
Eliquis	Apixaban	62	suppressed
Fluticasone Propionate	Fluticasone Propionate	62	22
Mirtazapine	Mirtazapine	58	suppressed
Simvastatin	Simvastatin	57	17
Buspirone Hcl	Buspirone Hcl	55	14
Metoprolol Tartrate	Metoprolol Tartrate	54	12
Gabapentin	Gabapentin	51	22
Metformin Hcl	Metformin Hcl	50	15
Rosuvastatin Calcium	Rosuvastatin Calcium	49	18
Metformin Hcl Er	Metformin Hcl	47	14
Citalopram Hbr	Citalopram Hydrobromide	45	suppressed
Baclofen	Baclofen	42	16
Fluoxetine Hcl	Fluoxetine Hcl	39	suppressed
Metoprolol Succinate	Metoprolol Succinate	35	11
Atenolol	Atenolol	34	suppressed
Pregabalin	Pregabalin	34	suppressed
Linzess	Linaclotide	33	suppressed
Potassium Chloride	Potassium Chloride	29	suppressed
Pravastatin Sodium	Pravastatin Sodium	29	suppressed
Tramadol Hcl	Tramadol Hcl	29	17
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Levetiracetam	Levetiracetam	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	suppressed
Phenobarbital	Phenobarbital	26	suppressed
Warfarin Sodium	Warfarin Sodium	25	suppressed
Ezetimibe	Ezetimibe	24	suppressed
Ipratropium Bromide	Ipratropium Bromide	24	suppressed
Nifedipine Er	Nifedipine	24	suppressed
Synthroid	Levothyroxine Sodium	24	suppressed
Spironolactone	Spironolactone	23	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	22	18
Bupropion Xl	Bupropion Hcl	22	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	suppressed
Glipizide	Glipizide	21	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Allopurinol	Allopurinol	19	suppressed
Clonazepam	Clonazepam	19	suppressed
Jardiance	Empagliflozin	19	suppressed
Oxycodone Hcl	Oxycodone Hcl	19	15
Ozempic	Semaglutide	18	suppressed
Prednisone	Prednisone	18	17
Divalproex Sodium	Divalproex Sodium	17	suppressed
Nystatin	Nystatin	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	11
Verapamil Er	Verapamil Hcl	17	suppressed
Alprazolam	Alprazolam	16	suppressed
Clopidogrel	Clopidogrel Bisulfate	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Tradjenta	Linagliptin	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Gemfibrozil	Gemfibrozil	14	suppressed
Naproxen	Naproxen	14	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	14	suppressed
Alendronate Sodium	Alendronate Sodium	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Cryselle	Norgestrel-Ethinyl Estradiol	12	suppressed
Procysbi	Cysteamine Bitartrate	12	suppressed
Amantadine	Amantadine Hcl	11	suppressed
Colchicine	Colchicine	11	suppressed
Diazepam	Diazepam	11	suppressed
Lacosamide	Lacosamide	11	suppressed
Levocarnitine	Levocarnitine (With Sugar)	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error